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Abstract
Hyperplastic changes of the thymus may be found in patients with Graves’ disease. However, this rarely presents as
an anterior mediastinal mass, particularly among adults. In this report, we describe a 46-year old woman with
Graves’ disease and thymic hyperplasia.
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Introduction
Thymic hyperplasia (TH) is a common feature in
Graves’ disease (GD) and the relationship between GD
and thymic changes is discussed [1,2]. However, in most
cases, thymic enlargement is minimal. Recognizing the
association between TH and GD, and existence of the
benign course after treatment of the hyperthyroidism
may be useful for avoiding unnecessary surgical
procedure.
We report a 46-year-old 40 × 30 × 50 mm, woman
with GD and hyperthyroidism. She had an anterior med-
iastinal mass that was diagnosed as TH and disappeared
after treatment of the hyperthyroid state.
Case report
A 46 year-old-woman was referred to our hospital,
because of weakness and hemopthaesia. Medical history,
social history, and family history were non contributory,
and the patient took no medications. Her physical
examination was normal. The thyroid gland did not
appear prominent. Results of routine laboratory studies
were all normal. Thyroid function tests demonstrated as
f o l l o w s :f r e eT 4t ob e5 . 8n g / d L( n o r m a lr a n g e ,1 . 0t o
1.8), and thyroid-stimulating hormone to be < 0.005 u
IU/mL (normal range, 0.3 to 4.0). Comptud tomography
scan of the chest revealed well-circumscribed soft tissue
density mass, 30 mm in size, with a regular periphery in
the anterior médiastinum.
Thyroid-directed antibodies were negatives: anti-thyro-
globulin antibody, and antimicrosomal antibody. TSH-
receptor antibody were positive. Anti-acetylcholine
receptor antibodies and prostigmine test were negatives.
The diagnosis of Grave’s disease associated to thy-
moma was made. She was treated with 30 mg per day
of Benzylthiouracile (200 mg per day) for several weeks
and became clinically euthyroid. Three months later sur-
gery, the anterior mediastinal mass disappeared on a
repeat computed tomographic scan of the chest.
Discussion
Thymic hyperplasia is a common and reversible feature
in patients with GD and hyperthyroidism [1,2]. In most
cases, thymic hypertrophy is minimal and unapparent.
Therefore, radiologically detectable thymic enlargement
as an anterior mediastinal mass with thyrotoxicosis has
been infrequently reported. Half of these cases undergo
thymectomy because they are suspected of having thy-
moma. Recognition of the benign nature of TH and its
regression following treatment of the hyperthyroidism is
important to prevent unnecessary surgical procedures
Michie and Gunn report that approximately 38% of
patients with thyrotoxicosis have histologic changes of
the thymus gland [6].
Graves disease is an autoimmune disorder character-
ized by thyroid enlargement and hyperthyroidism. Thyr-
otropin receptor (TSHR) autoantibodies bind the TSHR
on the membrane of thyroid follicular cells and stimu-
late cell proliferation and thyroid-hormone synthesis.
TSHR has also been identified in extrathyroidal organs,
including the human thymus [7].
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(AMM) in GD could thus sometimes turn out to be TH
and not a thymoma [8]; however, Levy and Lee noted
that GD can also be associated with invasive malignant
thymoma [9,10].
TH is a common feature in GD. However, in most
cases, thymic enlargement is minimal, and radiologically
detectable massive enlargement of the thymus is infre-
quently reported. Half of them undergo thymectomy
due to the concern about a thymoma [11].
The differential diagnosis of an AMM includes several
malignant lesions with a risk often warranting early sur-
gical excision. In light of the association of benign TH
with GD, thymectomy may be delayed in expectation of
thymic regression with medical therapy. The timing of
regression is variable, and very few reports exist in the
literature [1-12].
The mechanism of TH in hyperthyroidism and GD is
not well established. Van Herle and Chopra [13]
described that hyperthyroidism persists after thymect-
omy, and Scheiff and colleagues [14] reported that
administration of triiodothyronine can induce thymic
enlargement in mice. Murakami and colleagues [15]
investigated thymic size and density in 23 untreated
patients with GD and 38 control subjects using com-
puted tomography. The patients with GD had larger
thymic size and higher thymic density than age-matched
control subjects. After treatment with anti-thyroid
d r u g s ,b o t ht h y m i cs i z ea n dd e n s i t yw e r es i g n i f i c a n t l y
reduced with a concomitant decrease in thyroid-stimu-
lating hormone receptor antibodies. Murakami and col-
leagues [15] also clearly showed the presence of
thyrotropin receptors in the nonneoplastic thymic tissue
by polymerase chain reaction amplification, Northern
and Western blot analysis, and immunohistochemistry.
These results indicate that TH is apparently associated
with GD, and suggest that a thymic thyrotropin receptor
may act as an autoantigen that may be involved in the
pathophysiology of development of GD.
Conclusion
If an AMM in a thyrotoxic patient is detected on a
computed tomographic scan of the chest, and if it is a
homogeneous mass with no invasion to the neighboring
tissue, and no calcification, no septum, and no cystic
lesion, then a high priority should be given to the treat-
ment of the patient’s hyperthyroidism under close radi-
ologic follow-up of the AMM. If the size of the mass
does not decrease in spite of keeping a euthyroid state
for several months, we should take minimal invasive
diagnostic maneuvers such as a thoracoscopic procedure
or a cervical approach.
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